trending Market Intelligence /marketintelligence/en/news-insights/trending/oW-BDkM7oNA2kSQXdkbHCw2 content esgSubNav
In This List

Aradigm regains compliance with Nasdaq listing rule

Blog

Post-webinar Q&A: Global Credit Risk Trends 2021 and Beyond

Blog

University Essentials: From Crisis to Resilience – Navigating Sustainable Recovery

Blog

EV impact; vaccines to boost job market; coal supply constraints

Blog

Shore Capital is Now Available in S&P Global’s Aftermarket Research Collection


Aradigm regains compliance with Nasdaq listing rule

Aradigm Corp. regained compliance with the Nasdaq listing rule requiring the company to maintain a market value of listed securities of $35 million or greater for 10 consecutive business days.

The specialty pharmaceutical company received a noncompliance notice from Nasdaq on April 4, saying the company did not comply with the minimum requirement of $2.5 million stockholders' equity, or $35 million market value of listed securities, or $500,000 of net income from continuing operations.

Aradigm will continue to be listed on the Nasdaq Capital Market.